Pitofsky Jason sold REGN
February 9, 2026 · Form 4 insider transaction
Pitofsky Jason sold 1 shares of Regeneron Pharmaceuticals, Inc. at $784.66 per share, a transaction worth $784.66. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1
Price
$784.66
Total value
$784.66
InsiderPitofsky Jason
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after4,325
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025.